Ovarian cancer
Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains.
... in ovarian tumors compared to most normal tissues ...in ovarian cancer tissue include TIMP1, IGFBP3 (insulin-like growth factor-binding protein 3), MDK (midkine), PROS1 (vitamin k-dependent protein ...
10
Relationship between matrix metalloproteinases and the occurrence and development of ovarian cancer
... of ovarian cancer through mesothelin (MSLN)- activated MAPK/ERK and JNK pathways ...of ovarian cancer ...benign ovarian tumors, but overexpressed in the epithelium of ovarian ...
8
FOXM1 modulates cisplatin sensitivity by regulating EXO1 in ovarian cancer.
... in ovarian cancer, and that FOXM1 overexpression was significantly correlated with high-grade ovarian cancers, indicating that FOXM1 may play an oncogenic role in ovarian cancer ...of ...
10
Type-specific cell line models for type-specific ovarian cancer research.
... endometriosis-associated ovarian cancer diagnosis as does the presence of a PIK3CA ...associated ovarian cancer biology though care should be undertaken to allow proper interpretation of the ...
13
Transcriptional and epigenetic regulation of KIF14 overexpression in ovarian cancer.
... MicroRNAs (miRNAs) are a large, extensively studied group of small non-coding RNAs that downregulate protein expression by targeting mRNA translation and/or stability [27]. miRNAs have been implicated in the control of ...
13
Tumor stress-induced phosphoprotein1 (STIP1) as a prognostic biomarker in ovarian cancer.
... human ovarian cancer. In addition, STIP1 secreted by human ovarian cancer cells has been shown to promote tumor cell proliferation by binding to ALK2 (activin A receptor, type II-like kinase ...
9
Quality of life in ovarian cancer survivors
... and Stehman, 2012). Qualitative studies and Quality of Life studies have shown that significant distress, impairments in physical, vocational, social, familial and sexual functioning may also occur (WHOQOL, 1993; Bowling ...
8
Skeletal Muscle Depletion and Markers for Cancer Cachexia Are Strong Prognostic Factors in Epithelial Ovarian Cancer.
... Multiplexed Luminex-based assays are reliable to investigate the role of selected markers in cancer [16]. We measured circulating levels of cytokine and inflammation markers (IL-1β, IL- 1RA, IL-2, IL-2R, IL-4, ...
13
Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers.
... of ovarian cancer remain elusive, and there is a need for a wider search for novel, informative, cancer markers and ...discriminate ovarian cancer from normal and benign ...of ...
10
Endometriosis and ovarian cancer : an integrative review (Endometriosis and Ovarian Cancer)
... especially ovarian endometriomas are neoplastic conditions with the potential to become ...to ovarian cancer, published in the past ive ...epithelial ovarian cancer (EOC), mainly of ...
6
SERPINB3 in the chicken model of ovarian cancer: a prognostic factor for platinum resistance and survival in patients with epithelial ovarian cancer.
... human ovarian cancer tissues, representative core tissue sections (2 mm in diameter) were taken from paraffin blocks and arranged in new tissue microarray (TMA) blocks using trephine apparatus (Superb- ...
10
Effects of blood collection conditions on ovarian cancer serum markers.
... from ovarian cancer patients presents a significant challenge to researchers trying to discover or validate novel biomarkers for early ...from cancer patients that are available for research are not ...
6
Update on Imaging of Ovarian Cancer
... of ovarian, fallopian tube, and primary peritoneal cancer in ...than ovarian cancer [8, 9, ...from ovarian origin has often been ...primary ovarian cancer no longer exists ...
11
Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis.
... The major clinical challenge in the treatment of high-grade serous ovarian cancer (HGSOC; the most common type of ovarian cancer) is the development of resistance to platinum-based ...
20
REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker.
... of ovarian neoplasms rely on ultrasound imaging and the serum biomarkers CA125 and ...mucinous ovarian cancer ...epithelial ovarian tumors was further confirmed by mRNA ...of ovarian ...
13
Preclinical therapeutic potential of a nitrosylating agent in the treatment of ovarian cancer.
... Figure 7. Detection of STAT3 as S-nitrosylating protein by biotin switch method. A. Detection of biotinylated proteins after biotin-switch method in the presence or absence of S-nitrosoglutathione (GSNO; 0.5 mM). ...
11
Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors.
... for Cancer Research reported ovarian cancer as the gynecological malignancy with the highest case-to-mortality ratio ...the cancer has spread into the peritoneal cavity and metastasized to ...
20
Ovarian cancer in palliative care: a case report
... The ovarian cancer is the most common which starts in its epithelial cells (80%), ...it. Ovarian tumors are more prevalent in women in the menopause and contraceptive use reduces the risk of its ...
8
Gemcitabine eliminates double minute chromosomes from human ovarian cancer cells.
... pancreatic cancer, bladder cancer, breast cancer, and ovarian cancer ...from ovarian cancer cell lines at low nanomolar ...from ovarian cancer cell lines and ...
12
Endometrial Tuberculosis Simulating an Ovarian Cancer
... Female genital tuberculosis remains a major health problem in developing countries and is an important cause of infertility. As symptoms, laboratory data and physical indings are non-speciic, its diagnosis can be ...
4